Roche launches cobas pure integrated solutions analyser
Equipment

Roche launches cobas pure integrated solutions analyser

Cobas pure provides clinical labs with access to more than 230 diagnostic tests across a wide range of disease areas including infectious diseases, oncology and cardiology

  • By IPP Bureau | September 30, 2021

Roche Diagnostics India announced the launch of cobas pure integrated solutions analyser with a more intelligent system particularly suitable for a large number of labs and hospitals operating in India, to make better use of their space and expand their offering of high medical value tests for the benefit of patients.

This new compact analyser combines clinical chemistry, immunoassay and Ion Concentration Measurement (ISE) diagnostic testing on a single platform, helping labs simplify daily operations with limited space and resources. Cobas pure analyser offers longest onboard stability of reagents allowing labs to expand their test menu.

Announcing the launch, Narendra Varde, Managing Director, Roche Diagnostic India and Neighboring Markets said, "Cobas pure offers diverse critical and complex tests for patients. This consolidation of the test menu would enable labs to speedily perform hundreds of different tests using just a single test tube of blood sample from patients. Through cobas pure, the consolidated test menu can reach beyond metros into a large number of cities where testing menu may be presently limited."

Built on the latest technology, cobas pure integrated solutions analyser provides labs with an integrated system that focuses on the automation of manual tasks. This reduces the hands-on maintenance time of technicians to just 5 minutes per day which is 80 per cent less than previous generation systems. This will help improve the productivity of lab personnel whilst also enabling faster delivery of test results and clinical decision-making.

With a footprint of just two square meters, cobas pure analyser is smaller than previous generation systems. It is able to perform up to 870 tests per hour whilst providing medium-sized labs with access to the full clinical chemistry and immunochemistry assay menu from Roche, which includes more than 230 diagnostic tests across a wide range of disease areas such as critical care, infectious diseases, including Covid-19, Women's Health, Oncology, Cardiology, Endocrinology and TDM (Therapeutic Drug Monitoring).

Upcoming E-conference

Other Related stories

Startup

Digitization